BHIC Bioscience Health Innovations Inc.
Fundamentals / CIK 0001784440 / USDBioscience Health Innovations Inc. reported $4.33M in revenue and a net loss of $799K for the trailing twelve months ended September 30, 2026 (down 14.3% year over year), with a 54.4% gross margin and a -17.4% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BHIC in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$4.33M -14.3% YoY
-
Operating Income TTM-$753K -17.4% margin
-
Net Income TTM-$799K -18.4% net margin
-
Diluted EPS TTM-$0.07 Split-adjusted
-
Free Cash Flow TTM-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$1.69M Total debt: --
Annual revenue and net income
7 fiscal years (2020 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Aug 31 | Aug 31 | Aug 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $5.69M | $1.84M | $598K | $69K | $0 | $0 | $0 |
| Cost of Revenue | $2.45M | $536K | $113K | $9.7K | -- | -- | -- |
| Gross Profit | $3.24M | $1.31M | $484K | $60K | -- | -- | -- |
| Research & Development | $38K | $26K | $0 | -- | -- | -- | -- |
| Selling, General & Admin | $2.21M | $1.15M | $706K | $151K | $92K | $26K | $7.7K |
| Total Operating Expenses | $2.52M | $1.22M | $736K | $230K | $92K | $26K | $7.7K |
| Operating Income | $719K | $87K | -$252K | -$170K | -$92K | -$26K | -$7.7K |
| Interest Expense | -- | -- | -- | -- | -- | $450 | -- |
| Income Before Tax | -- | -- | -- | -- | -$83K | -$26K | -- |
| Income Tax Expense | $77K | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | $642K | $87K | -$252K | -$170K | -$83K | -$26K | -$7.7K |
| Basic EPS | $0.23 | $0.04 | -$0.04 | -- | -- | $0.00 | $0.00 |
| Diluted EPS | $0.23 | $0.04 | -$0.04 | -- | -- | $0.00 | $0.00 |
| Basic Shares Outstanding | 2.8M | 2.7M | 8.7M | -- | -- | 1.4M | 975.4K |
| Diluted Shares Outstanding | 2.9M | 2.8M | 8.7M | -- | -- | 1.4M | 975.4K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $970K | $1.04M | $751K | $1.57M | $1.13M | $1.76M | $1.23M | $610K |
| Cost of Revenue | $333K | $377K | $265K | $1.00M | $433K | $683K | $331K | $271K |
| Gross Profit | $638K | $659K | $486K | $572K | $698K | $1.07M | $896K | $339K |
| Research & Development | $60K | $71K | $50K | -$29K | $20K | $9.2K | $38K | -$3.9K |
| Selling, General & Admin | -- | -- | $626K | $656K | $577K | $540K | $434K | $300K |
| Total Operating Expenses | $786K | $877K | $716K | $729K | $707K | $617K | $469K | $329K |
| Operating Income | -$148K | -$218K | -$230K | -$157K | -$8.8K | $458K | $427K | $10.0K |
| Interest Expense | $965 | -- | -- | -- | $0 | -- | -- | -- |
| Income Tax Expense | $0 | -$32K | -- | -- | $0 | $0 | -- | -- |
| Net Income | -$149K | -$186K | -$230K | -$234K | -$8.8K | $458K | $427K | $10.0K |
| Basic EPS | -$0.01 | -$0.02 | -$0.08 | -- | $0.00 | $0.04 | $0.04 | -- |
| Diluted EPS | -$0.01 | -$0.02 | -$0.08 | -- | $0.00 | $0.04 | $0.04 | -- |
| Basic Shares Outstanding | 11.8M | 11.7M | 2.9M | -- | 11.0M | 11.0M | 11.3M | -- |
| Diluted Shares Outstanding | 11.8M | 11.7M | 2.9M | -- | 11.0M | 11.4M | 11.4M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $662K | $663K | $19K | $12K | $16K | $2.0K | $21K | $0 |
| Cash & Short-Term Investments | $662K | $663K | $19K | $12K | $16K | $2.0K | $21K | $0 |
| Accounts Receivable, Net | $399K | $100K | $36K | $7.8K | -- | -- | -- | -- |
| Inventory | $336K | $58K | $38K | $12K | -- | -- | -- | -- |
| Total Current Assets | $1.56M | $848K | $93K | $32K | $16K | $6.3K | $21K | -- |
| Intangible Assets | $83K | $26K | $0 | -- | -- | -- | -- | -- |
| Total Non-Current Assets | $149K | $26K | $0 | $0 | $0 | $0 | $0 | -- |
| Total Assets | $1.71M | $874K | $93K | $32K | $16K | $6.3K | $21K | $1.9K |
| Accounts Payable | $6.3K | $8.2K | $7.7K | $3.4K | $1.9K | $0 | $760 | $0 |
| Deferred Revenue (Current) | $137K | $24K | $3.9K | $0 | -- | -- | -- | -- |
| Other Current Liabilities | -- | -- | -- | -- | -- | $0 | -- | -- |
| Total Liabilities | $230K | $39K | $100K | $49K | $1.9K | $19K | $7.8K | $0 |
| Common Stock | $1.1K | $4.4K | $4.1K | $546 | $546 | $546 | $546 | $280 |
| Retained Earnings | $301K | -$341K | -$428K | -$177K | -$117K | -$34K | -$8.6K | -$900 |
| Total Stockholders' Equity | $1.48M | $835K | -$6.8K | -$17K | $14K | -$13K | $13K | $1.9K |
| Total Equity | $1.48M | $835K | -$6.8K | -$17K | $14K | -$13K | $13K | $1.9K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $1.69M | $712K | $1.15M | $662K | $1.14M | $1.30M | $1.03M | $663K |
| Cash & Short-Term Investments | $1.69M | $712K | $1.15M | $662K | $1.14M | $1.30M | $1.03M | $663K |
| Accounts Receivable, Net | $478K | $397K | $78K | $399K | $63K | $390K | $93K | $100K |
| Inventory | $711K | $797K | $874K | $336K | $758K | $249K | $216K | $58K |
| Total Current Assets | $3.01M | $1.99M | $2.19M | $1.56M | $1.99M | $1.99M | $1.34M | $848K |
| Intangible Assets | $170K | $110K | $83K | $83K | $72K | $72K | $56K | $26K |
| Total Non-Current Assets | $197K | $149K | $135K | $149K | $72K | $72K | $56K | $26K |
| Total Assets | $3.20M | $2.14M | $2.33M | $1.71M | $2.07M | $2.06M | $1.39M | $874K |
| Accounts Payable | $39K | $9.7K | $6.8K | $6.3K | $10K | $17K | $16K | $8.2K |
| Deferred Revenue (Current) | $1.5K | $2.5K | $77K | $137K | $111K | $249K | $50K | $24K |
| Total Liabilities | $282K | $301K | $646K | $230K | $356K | $338K | $133K | $39K |
| Common Stock | $1.2K | $1.2K | $1.1K | $1.1K | $1.1K | $4.4K | $4.4K | $4.4K |
| Retained Earnings | -$264K | -$115K | $71K | $301K | $535K | $543K | $86K | -$341K |
| Total Stockholders' Equity | $2.92M | $1.83M | $1.68M | $1.48M | $1.71M | $1.72M | $1.26M | $835K |
| Total Equity | $2.92M | $1.83M | $1.68M | $1.48M | $1.71M | $1.72M | $1.26M | $835K |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Aug 31 | Aug 31 | Aug 31 |
|---|---|---|---|---|---|---|---|
| Net Income | $642K | $87K | -$252K | -$170K | -$83K | -$26K | -$7.7K |
| Stock-Based Compensation | -- | -- | $0 | $225 | -- | -- | -- |
| Change in Receivables | -$299K | -$64K | -$29K | -$7.8K | -- | -- | -- |
| Change in Inventory | -$278K | -$21K | -$25K | -$12K | -- | -- | -- |
| Change in Payables | -$2.0K | $551 | -$7.6K | $0 | $1.9K | $0 | -- |
| Operating Cash Flow | $172K | $23K | -$308K | -$183K | -$86K | -$29K | -$7.7K |
| Investing Cash Flow | -$57K | -$26K | $0 | $0 | -- | -- | $0 |
| Common Stock Issued | $0 | $755K | $265K | $150K | -- | $0 | $27K |
| Financing Cash Flow | -$116K | $646K | $316K | $194K | $100K | $11K | $28K |
| Net Change in Cash | -$592 | $643K | $7.7K | $11K | $14K | -$19K | $21K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$149K | -$186K | -$230K | -$234K | -$8.8K | $458K | $427K | $10.0K |
| Change in Receivables | -$81K | -$319K | $321K | -$336K | $327K | -$297K | $6.8K | -$68K |
| Change in Inventory | $128K | $81K | -$538K | $421K | -$509K | -$33K | -$157K | -$16K |
| Change in Payables | -- | -- | -- | -$3.9K | -$6.5K | $221 | $8.2K | -$221 |
| Operating Cash Flow | -$151K | -$542K | -$552K | -$101K | -$340K | $285K | $328K | -$50K |
| Investing Cash Flow | -$60K | -$27K | $0 | -$11K | $0 | -$16K | -$30K | -$19K |
| Common Stock Issued | $1.24M | $336K | $437K | $0 | $0 | $0 | $0 | $455K |
| Financing Cash Flow | $1.19M | $136K | $1.04M | -$366K | $180K | $2.1K | $68K | $399K |
| Net Change in Cash | $979K | -$433K | $483K | -$477K | -$160K | $271K | $366K | $329K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Aug 31 | Aug 31 | Aug 31 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 57.0% | 70.9% | 81.1% | 86.0% | -- | -- | -- |
| Operating Margin | 12.6% | 4.7% | -42.1% | -245.8% | -- | -- | -- |
| Net Profit Margin | 11.3% | 4.7% | -42.1% | -245.8% | -- | -- | -- |
| Return on Equity (ROE) | 43.5% | 10.4% | -- | -- | -578.1% | -- | -59.9% |
| Return on Assets (ROA) | 37.6% | 10.0% | -269.3% | -539.3% | -512.0% | -405.6% | -37.2% |
| Revenue Growth (YoY) | +208.3% | +208.7% | +761.8% | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | +147.6% | +170.2% | +712.2% | -- | -- | -- | -- |
| Operating Income Growth (YoY) | +726.5% | -- | -- | -- | -- | -- | -- |
| Net Income Growth (YoY) | +638.0% | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | +500.0% | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | +642.5% | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 54.4% | 53.8% | 54.3% | 57.0% | 63.6% | 65.6% | 70.5% | 70.9% |
| Operating Margin | -17.4% | -13.7% | 1.2% | 12.6% | 18.7% | 22.8% | 20.3% | 4.7% |
| Net Profit Margin | -18.4% | -14.7% | -0.3% | 11.3% | 18.7% | 22.8% | 20.3% | 4.7% |
| Return on Equity (ROE) | -27.3% | -35.9% | -0.9% | 43.5% | 51.8% | 55.3% | 44.9% | 10.4% |
| Return on Assets (ROA) | -24.9% | -30.8% | -0.6% | 37.6% | 42.8% | 46.2% | 40.7% | 10.0% |
| Revenue Growth (YoY) | -14.3% | -41.0% | -38.8% | +157.7% | +97.5% | +357.5% | +342.0% | +101.0% |
| Gross Profit Growth (YoY) | -8.7% | -38.6% | -45.8% | +68.7% | +64.4% | +246.2% | +281.7% | +43.3% |
| Operating Income Growth (YoY) | -- | -147.6% | -153.9% | -1673.5% | -115.6% | +516.7% | -- | -- |
| Net Income Growth (YoY) | -- | -140.6% | -153.9% | -2446.4% | -115.6% | +516.7% | -- | -- |
| EPS Growth (YoY) | -- | -150.0% | -300.0% | -- | -100.0% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -290.1% | -268.2% | -- | -751.8% | +311.3% | -- | -- |